News
Background: The MOSAIC study compared moxifloxacin with three standard antibiotic regimens in patients with Anthonisen type 1 acute exacerbations of chronic bronchitis (AECB). Further exploratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback